Eli Lilly and Co
SIX:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
SIX:LLY
Watchlist
Price: 296 CHF -0.67%
Market Cap: 885.9B CHF

Wall Street
Price Targets

LLY Price Targets Summary
Eli Lilly and Co

Wall Street analysts forecast LLY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LLY is 801.57 CHF with a low forecast of 559.89 CHF and a high forecast of 1 236.61 CHF.

Lowest
Price Target
559.89 CHF
89% Upside
Average
Price Target
801.57 CHF
171% Upside
Highest
Price Target
1 236.61 CHF
318% Upside
Eli Lilly and Co Competitors:
Price Targets
DMP
Dermapharm Holding SE
14% Upside
AQST
Aquestive Therapeutics Inc
81% Upside
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
28% Downside
UCB
Ucb SA
10% Upside
600276
Jiangsu Hengrui Pharmaceuticals Co Ltd
34% Upside
GRANULES
Granules India Ltd
5% Upside

Revenue
Forecast

Revenue Estimate
Eli Lilly and Co

For the last 13 years the compound annual growth rate for Eli Lilly and Co's revenue is 5%. The projected CAGR for the next 4 years is 22%.

5%
Past Growth
22%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Eli Lilly and Co

For the last 13 years the compound annual growth rate for Eli Lilly and Co's operating income is 8%. The projected CAGR for the next 4 years is 30%.

8%
Past Growth
30%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Eli Lilly and Co

For the last 13 years the compound annual growth rate for Eli Lilly and Co's net income is 7%. The projected CAGR for the next 4 years is 42%.

7%
Past Growth
42%
Estimated Growth
Estimates Accuracy
-12%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LLY's stock price target?
Price Target
801.57 CHF

According to Wall Street analysts, the average 1-year price target for LLY is 801.57 CHF with a low forecast of 559.89 CHF and a high forecast of 1 236.61 CHF.

What is Eli Lilly and Co's Revenue forecast?
Projected CAGR
22%

For the last 13 years the compound annual growth rate for Eli Lilly and Co's revenue is 5%. The projected CAGR for the next 4 years is 22%.

What is Eli Lilly and Co's Operating Income forecast?
Projected CAGR
30%

For the last 13 years the compound annual growth rate for Eli Lilly and Co's operating income is 8%. The projected CAGR for the next 4 years is 30%.

What is Eli Lilly and Co's Net Income forecast?
Projected CAGR
42%

For the last 13 years the compound annual growth rate for Eli Lilly and Co's net income is 7%. The projected CAGR for the next 4 years is 42%.

Back to Top